6 in 10 Austrialians in care take antidepressants … Pneumococcal shot could do double duty to fight viral respiratory infections … Study: Rebounds occurred with both COVID-19 antivirals … Quest stops...
Palliative care screening in ICU may lead to better patient outcome
By
Donna Shryer
Apr 03, 2024
In the intensive care unit, every second counts when treating critically ill patients. But among the cutting-edge technologies, there is rarely any sort of defined process to swiftly identify patients...
Clinical Briefs for Tuesday, July 21
By
Alicia Lasek
Jul 21, 2020
Oldest, most frail adults may benefit from hospitalization for COVID-19, study finds … Coronavirus vaccine trial a ‘major breakthrough,’ claims drugmaker … Quest Diagnostics is first to gain...
Low-dose brain radiation improves behavior, cognition in Alzheimer’s pilot study
By
Alicia Lasek
May 04, 2021
Low-dose ionizing radiation may be a promising, although possibly controversial, therapy for Alzheimer’s disease, according to the researchers behind a small new pilot study.
Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Clinical briefs for Monday, Nov. 2
Nov 01, 2020
State stockpiling orders hurting nursing homes on PPE quest … Aspirin use best for those with high coronary calcium, low risk of bleeding … Myocarditis linked to COVID-19 not as common as believed:...
Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...
CVS: Independent living residents will continue to wait for COVID-19 vaccination
By
Kimberly Bonvissuto
Jan 06, 2021
Independent living residents, even those who live in CCRCs, will have to continue to wait for COVID-19 vaccination, according to one of the retail giants administering the vaccines in long-term care.
Aduhelm’s costs: Medicare recipients won’t get premium reduction until 2023
By
Alicia Lasek (f3)
Jun 01, 2022
A cost overestimate that bumped up Medicare premiums for seniors in 2022 will not be corrected until the following year. The spike is tied to coverage for Alzheimer’s drug Aduhelm.
Benefits of Alzheimer’s drug Leqembi persist when treatment is halted, trial shows
By
Alicia Lasek
Apr 09, 2023
A relative slowing of cognitive decline continues for up to two years in patients who stop taking the recently authorized drug, clinical trial data reveal.